189 related articles for article (PubMed ID: 31540474)
1. A Novel CXCR4 Targeting Protein SDF-1/54 as an HIV-1 Entry Inhibitor.
Tan S; Li W; Li Z; Li Y; Luo J; Yu L; Yang J; Qiu M; Cheng H; Xu W; Jiang S; Lu L; Liu S; Ma W
Viruses; 2019 Sep; 11(9):. PubMed ID: 31540474
[TBL] [Abstract][Full Text] [Related]
2. The molecular pharmacology of AMD11070: an orally bioavailable CXCR4 HIV entry inhibitor.
Mosi RM; Anastassova V; Cox J; Darkes MC; Idzan SR; Labrecque J; Lau G; Nelson KL; Patel K; Santucci Z; Wong RS; Skerlj RT; Bridger GJ; Huskens D; Schols D; Fricker SP
Biochem Pharmacol; 2012 Feb; 83(4):472-9. PubMed ID: 22146583
[TBL] [Abstract][Full Text] [Related]
3. Optimal inhibition of X4 HIV isolates by the CXC chemokine stromal cell-derived factor 1 alpha requires interaction with cell surface heparan sulfate proteoglycans.
Valenzuela-Fernández A; Palanche T; Amara A; Magerus A; Altmeyer R; Delaunay T; Virelizier JL; Baleux F; Galzi JL; Arenzana-Seisdedos F
J Biol Chem; 2001 Jul; 276(28):26550-8. PubMed ID: 11352904
[TBL] [Abstract][Full Text] [Related]
4. HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication.
Amara A; Gall SL; Schwartz O; Salamero J; Montes M; Loetscher P; Baggiolini M; Virelizier JL; Arenzana-Seisdedos F
J Exp Med; 1997 Jul; 186(1):139-46. PubMed ID: 9207008
[TBL] [Abstract][Full Text] [Related]
5. Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors.
Choi WT; Tian S; Dong CZ; Kumar S; Liu D; Madani N; An J; Sodroski JG; Huang Z
J Virol; 2005 Dec; 79(24):15398-404. PubMed ID: 16306611
[TBL] [Abstract][Full Text] [Related]
6. Cloning and characterizing mutated human stromal cell-derived factor-1 (SDF-1): C-terminal alpha-helix of SDF-1alpha plays a critical role in CXCR4 activation and signaling, but not in CXCR4 binding affinity.
Tan Y; Du J; Cai S; Li X; Ma W; Guo Z; Chen H; Huang Z; Xiao J; Cai L; Cai S
Exp Hematol; 2006 Nov; 34(11):1553-62. PubMed ID: 17046575
[TBL] [Abstract][Full Text] [Related]
7. HIV co-receptors as targets for antiviral therapy.
Schols D
Curr Top Med Chem; 2004; 4(9):883-93. PubMed ID: 15134547
[TBL] [Abstract][Full Text] [Related]
8. The CXCR4 agonist ligand stromal derived factor-1 maintains high affinity for receptors in both Galpha(i)-coupled and uncoupled states.
Di Salvo J; Koch GE; Johnson KE; Blake AD; Daugherty BL; DeMartino JA; Sirotina-Meisher A; Liu Y; Springer MS; Cascieri MA; Sullivan KA
Eur J Pharmacol; 2000 Dec; 409(2):143-54. PubMed ID: 11104827
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides.
Heveker N; Montes M; Germeroth L; Amara A; Trautmann A; Alizon M; Schneider-Mergener J
Curr Biol; 1998 Mar; 8(7):369-76. PubMed ID: 9545196
[TBL] [Abstract][Full Text] [Related]
10. SDF-1-induced activation of ERK enhances HIV-1 expression.
Montes M; Tagieva NE; Heveker N; Nahmias C; Baleux F; Trautmann A
Eur Cytokine Netw; 2000 Sep; 11(3):470-7. PubMed ID: 11022134
[TBL] [Abstract][Full Text] [Related]
11. Blockade of X4-tropic HIV-1 cellular entry by GSK812397, a potent noncompetitive CXCR4 receptor antagonist.
Jenkinson S; Thomson M; McCoy D; Edelstein M; Danehower S; Lawrence W; Wheelan P; Spaltenstein A; Gudmundsson K
Antimicrob Agents Chemother; 2010 Feb; 54(2):817-24. PubMed ID: 19949058
[TBL] [Abstract][Full Text] [Related]
12. Role of CXCR4 internalization in the anti-HIV activity of stromal cell-derived factor-1α probed by a novel synthetically and modularly modified-chemokine analog.
Dong CZ; Tian S; Madani N; Choi WT; Kumar S; Liu D; Sodroski JG; Huang Z; An J
Exp Biol Med (Maywood); 2011 Dec; 236(12):1413-9. PubMed ID: 22101518
[TBL] [Abstract][Full Text] [Related]
13. X4 HIV-1 induces neuroblastoma cell death by interference with CXCL12/CXCR4 interaction.
Hatse S; Bridger G; de Clercq E; Schols D
Cell Mol Biol (Noisy-le-grand); 2003; 49 Online Pub():OL443-52. PubMed ID: 14995074
[TBL] [Abstract][Full Text] [Related]
14. Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication.
Maréchal V; Arenzana-Seisdedos F; Heard JM; Schwartz O
J Virol; 1999 May; 73(5):3608-15. PubMed ID: 10196252
[TBL] [Abstract][Full Text] [Related]
15. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.
Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T
J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity.
Hesselgesser J; Liang M; Hoxie J; Greenberg M; Brass LF; Orsini MJ; Taub D; Horuk R
J Immunol; 1998 Jan; 160(2):877-83. PubMed ID: 9551924
[TBL] [Abstract][Full Text] [Related]
17. Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitors.
Wu CH; Wang CJ; Chang CP; Cheng YC; Song JS; Jan JJ; Chou MC; Ke YY; Ma J; Wong YC; Hsieh TC; Tien YC; Gullen EA; Lo CF; Cheng CY; Liu YW; Sadani AA; Tsai CH; Hsieh HP; Tsou LK; Shia KS
J Med Chem; 2015 Feb; 58(3):1452-65. PubMed ID: 25584630
[TBL] [Abstract][Full Text] [Related]
18. Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4 transmembrane helical domains.
Tian S; Choi WT; Liu D; Pesavento J; Wang Y; An J; Sodroski JG; Huang Z
J Virol; 2005 Oct; 79(20):12667-73. PubMed ID: 16188969
[TBL] [Abstract][Full Text] [Related]
19. T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use.
Schols D; Esté JA; Cabrera C; De Clercq E
J Virol; 1998 May; 72(5):4032-7. PubMed ID: 9557691
[TBL] [Abstract][Full Text] [Related]
20. The CXC chemokine receptor 4 ligands ubiquitin and stromal cell-derived factor-1α function through distinct receptor interactions.
Saini V; Staren DM; Ziarek JJ; Nashaat ZN; Campbell EM; Volkman BF; Marchese A; Majetschak M
J Biol Chem; 2011 Sep; 286(38):33466-77. PubMed ID: 21757744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
